Key Insights

Highlights

Treatment Research

2 treatments under study, led by Usual Care Group

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Usual Care Group1
  • Technological Group1

Active Sponsors

  • Instituto de Investigacion Sanitaria La Fe1

Related Conditions

  • Transition To Discharge1
  • Continuous Glucose Monitoring1
  • Cgm1
  • Type 2 Diabetes Mellitus T2dm1

Activity Timeline